Liver resection for metastatic gastric cancer: Experience with 42 patients including eight long-term survivors

Japanese Journal of Clinical Oncology

Volumn 37, Issue 11, 2007, Pages 836-842

  Koga, Rintaro ^a   Yamamoto, Junji ^a   Ohyama, Shigekazu ^a   Saiura, Akio ^a   Seki, Makoto ^a   Seto, Yasuyuki ^a   Yamaguchi, Toshiharu ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Gastric cancer; Hepatectomy; Liver metastases; Prognostic factor

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PERITONEUM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDY; SEROSA; SKIN METASTASIS; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; SURVIVOR; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 37149036765     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hym113     Document Type: Article

References (35)

1. Ministry of Health LW. Vital Statistics of Japan, 2004; 290.
2. Otsuji E, Yamaguchi T, Sawai K, Hagiwara A, Taniguchi H, Takahashi T. Recent advances in surgical treatment have improved the survival of patients with gastric carcinoma. Cancer 1998;82:1233-7.
3. Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metagtases. Br J Surg 1999;86:332-7.
4. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: Long-term results. Ann Surg 2000;231:487-99.
5. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 2001;181:153-9.
6. Miyazaki M, Itoh H, Nakagawa K, Ambiru S, Shimizu H, Togawa A, et al. Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 1997;92:490-3.
7. Imamura H, Matsuyama Y, Shimada R, Kubota M, Nakayama A, Kobayashi A, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 2001;96:3178-84.
8. Yamamoto J, Sugihara K, Kosuge T, Takayama T, Shimada K, Yamasaki S, et al. Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 1995;221:74-8.
9. Yamamoto J, Saiura A, Koga R, Seki M, Ueno M, Oya M, et al. Surgical treatment for metastatic malignancies. Nonanatomical resection of liver metastasis: Indications and outcomes. Int J Clin Oncol 2005; 10:97-102.
10. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma, 13th edn. Kanehara & Co. Ltd: Tokyo, 1999.
11. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 2000;87:353-7.
12. Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11:418-25.
13. Kaibara N, Sumi K, Yonekawa M, Ohti M, Makino M, Kimura O, et al. Does extensive dissection of lymph nodes improve the results of surgical treatment of gastric cancer? Am J Surg 1990; 159:218-21.
14. Taniguchi H, Takahashi T, Sawai K, Yamaguchi T, Hagiwara A, Kitamura K, et al. Comparison in survival between hepatic metastases of gastric and colorectal cancers. Hepalogastroenterology 1997;44:897-900.
15. Marrelli D, Roviello F, De Stefano A, Fotia G, Giliberto C, Garosi L, et al. Risk factors for liver metastases after curative surgical procedures for gastric cancer: A prospective study of 208 patients treated with surgical resection. J Am Coll Surg 2004;198:51-8.
16. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-42.
17. Sakamoto Y, Ohyama S, Yamamoto J, Yamada K, Seki M, Ohta K, et al. Surgical resection of liver metastases of gastric cancer: An analysis of a 17-year experience with 22 patients. Surgery 2003;133:507-11.
18. Ochiai T, Sasako M, Mizuno S, Kinoshita T, Takayama T, Kosuge T, et al. Hepatic resection for metastatic tumours from gastric cancer: Analysis of prognostic factors. Br J Surg 1994;81:1175-8.
19. Ambiru S, Miyazaki M, Ito H, Nakagawa K, Shimizu H, Yoshidome H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg 2001; 181:279-83.
20. Okano K, Maeba T, Ishimura K, Karasawa Y, Goda F, Wakabayashi H, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 2002;235:86-91.
21. Shirabe K, Shimada M, Matsumata T, Higashi H, Yakeishi Y, Wakiyama S, et al. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: A multi-institutional study of the indications for resection. Hepatogastroenterology 2003;50:1560-3.
22. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J Surg 1995;19:59-71.
23. Maehara Y, Moriguchi S, Kakeji Y, Kohnoe S, Korenaga D, Haraguchi M, et al. Pertinent risk factors and gastric carcinoma with synchronous peritoneal dissemination or liver metastasis. Surgery 1991;110:820-3.
24. Irinoda, T, Terashima M, Takagane A, Sasaki N, Abe K, Araya M, et al. Carcinoembryonic antigen level in peritoneal washing is a prognostic factor in patients with gastric cancer. Oncol Rep 1998;5:661-6.
25. Kodera Y, Yamamma Y, Shimizu Y, Torii A, Hirai T, Yasui K, et al. Peritoneal washing cytology: Prognostic value of positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999;72:60-4; discussion 64-5.
26. Kodera Y, Nakanishi H, Ito S, Yamamura Y, Kanemitsu Y, Shimizu Y, et al. Quantitative detection of disseminated cancer cells in the greater omentum of gastric carcinoma patients with real-time RT-PCR: A comparison with peritoneal lavage cytology. Gastric Cancer 2002;5:69-76.
27. Noguchi Y, Yoshikawa T, Tsuburaya, A, Motohashi H, Karpeh MS, Brennan MF. Is gastric carcinoma different between Japan and the United States? Cancer 2000;89:2237-46.
28. Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 1993;80:1015-8.
29. Yoshizumi Y, Matuyama T, Koike H, Aiko S, Sugiura Y, Maehara T. Long-term survival after gastric cancer and liver and paraaortic lymph node metastases: Report of a case. Surg Today 2001;31:159-62.
30. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 1996;224:509-20; discussion 520-2.
31. Hallissey MT, Dunn JA, Ward LC, Allum WH. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: Five-year follow-up. Lancet 1994;343(8909):1309-12.
32. Nakajima, T, Nashimoto A, Kitamura. M, Kito T, Iwanaga T, Okabayashi K, et al. Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer. a randomised trial. Gastric Cancer Surgical Study Group. Lancet 1999;354(9175):273-7.
33. Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, et al. Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 2003;21:2282-7.
34. Yonemura Y, Matuki N, Sakuma H, Katayama K, Sawa T, Fujimura T, et al. Effect of intra-hepaloarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases. Surg Today 1992; 22:253-9.
35. Tarazov PG. Transcatheter therapy of gastric cancer metastatic to the liver: Preliminary results. J Gastroenterol 2000;35:907-11.